Where is the live CopyMark page for USPTO serial 78179537?

The live record is at https://getcopymark.com/trademark/78179537. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns BRISTOL-MYERS SQUIBB MEDICAL IMAGING?

According to the public USPTO record for serial number 78179537, the listed owner(s) include: Bristol-Myers Squibb Pharma Company, Bristol-Myers Squibb Pharma Company, Bristol-Myers Squibb Pharma Company.

What is USPTO serial number 78179537?

Serial number 78179537 is the USPTO application identifier for the mark BRISTOL-MYERS SQUIBB MEDICAL IMAGING. It is used to track examination, publication, and registration of this trademark.

What is the current status of BRISTOL-MYERS SQUIBB MEDICAL IMAGING?

BRISTOL-MYERS SQUIBB MEDICAL IMAGING (78179537) currently shows USPTO status code 711 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover BRISTOL-MYERS SQUIBB MEDICAL IMAGING?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: BRISTOL-MYERS SQUIBB MEDICAL IMAGING Serial# 78179537 | status 711; last event C7.. | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BRISTOL-MYERS SQUIBB MEDICAL IMAGING?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

NADINE P. FLYNN

GNADINE P. FLYNN BRISTOL-MYERS SQUIBB COMPANY345 PARK AVENEW YORK, NY 10154UNITED STATES

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, central nervous system diseases and disorders, diabetes, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases; antibiotics; contrasting agent for ultrasound diagnostic imaging	SECTION 7(e) - CANCELLED	Apr 29, 2003

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Oct 24, 2008	C7..	CANCELLED SECTION 7-TOTAL	—
Oct 15, 2008	ALIE	ASSIGNED TO LIE	—
Sep 10, 2008	C7RF	REQUEST FOR SECT 7 TOTAL SURRENDER FILED	—
Sep 10, 2008	MAIL	PAPER RECEIVED	—
Sep 21, 2004	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 26, 2004	REGV	LAW OFFICE REGISTRATION REVIEW COMPLETED	—
Jul 26, 2004	ALIE	ASSIGNED TO LIE	—
Jul 12, 2004	CNPR	ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED	—
Jul 6, 2004	DOCK	ASSIGNED TO EXAMINER	—
Jul 2, 2004	SUPC	STATEMENT OF USE PROCESSING COMPLETE	—
Jun 24, 2004	IUAF	USE AMENDMENT FILED	—
Jun 24, 2004	EISU	TEAS STATEMENT OF USE RECEIVED	The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 29, 2004	EX1G	SOU EXTENSION 1 GRANTED	—
Mar 23, 2004	EXT1	SOU EXTENSION 1 FILED	—
Mar 23, 2004	EEXT	SOU TEAS EXTENSION RECEIVED	The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 9, 2004	NOAM	NOA MAILED - SOU REQUIRED FROM APPLICANT	A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 16, 2003	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 26, 2003	NPUB	NOTICE OF PUBLICATION	—
Oct 20, 2003	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Sep 22, 2003	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Sep 22, 2003	MAIL	PAPER RECEIVED	—
Apr 9, 2003	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2003	DOCK	ASSIGNED TO EXAMINER	—

BRISTOL-MYERS SQUIBB MEDICAL IMAGING